Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases
Authors:
- 1 April 2021
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (4) , e415-e422
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Abstract 906:Gas1andKif27genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients2012
- Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of SmoothenedACS Medicinal Chemistry Letters, 2011
- Frequent Deregulations in the Hedgehog Signaling Network and Cross-Talks with the Epidermal Growth Factor Receptor Pathway Involved in Cancer Progression and Targeted TherapiesPharmacological Reviews, 2010
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell CarcinomaNew England Journal of Medicine, 2009
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemiaNature, 2009
- A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatmentCancer, 2007
- Inhibition of Hedgehog signaling by direct binding of cyclopamine to SmoothenedGenes & Development, 2002
- Medulloblastoma Growth Inhibition by Hedgehog Pathway BlockadeScience, 2002
- Conditional Disruption of Hedgehog Signaling Pathway Defines its Critical Role in Hair Development and RegenerationJournal of Investigative Dermatology, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997